Screening strategy for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting approximately 25% of the general population worldwide, and is forecasted to increase global health burden in the 21st century. With the advancement of non-invasive tests for assessing and monitoring of stea...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2022
|
| オンライン･アクセス: | https://doi.org/10.3350/cmh.2022.0336 https://www.e-cmh.org/upload/pdf/cmh-2022-0336.pdf |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|